Your browser doesn't support javascript.
loading
Brain hyperserotonemia causes autism-relevant social deficits in mice.
Tanaka, Miho; Sato, Atsushi; Kasai, Shinya; Hagino, Yoko; Kotajima-Murakami, Hiroko; Kashii, Hirofumi; Takamatsu, Yukio; Nishito, Yasumasa; Inagaki, Masumi; Mizuguchi, Masashi; Hall, F Scott; Uhl, George R; Murphy, Dennis; Sora, Ichiro; Ikeda, Kazutaka.
Afiliação
  • Tanaka M; 1Department of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
  • Sato A; 2Molecular and Cellular Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Kasai S; 3Department of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Hagino Y; 1Department of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
  • Kotajima-Murakami H; 4Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
  • Kashii H; 1Department of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
  • Takamatsu Y; 1Department of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
  • Nishito Y; 1Department of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
  • Inagaki M; 1Department of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
  • Mizuguchi M; 1Department of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan.
  • Hall FS; 5Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Uhl GR; 3Department of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Murphy D; 6Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Sora I; 7Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH USA.
  • Ikeda K; 8Branch of Molecular Neurobiology, National Institute on Drug Abuse, Baltimore, MD USA.
Mol Autism ; 9: 60, 2018.
Article em En | MEDLINE | ID: mdl-30498565
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article